ArticleBMC cancer2018

Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma.

Dennis Lindenblatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.